10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001193125-18-056057 |
| Period End Date | 20171231 |
| Filing Date | 20180223 |
| Fiscal Year | 2017 |
| Fiscal Period | FY |
| XBRL Instance | hca-20171231.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
85 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Allowance for Accounts receivable |
AllowanceForDoubtfulAccountsReceivable
|
$5.49B | USD | Point-in-time |
| Allowance for Accounts receivable |
AllowanceForDoubtfulAccountsReceivable
|
$4.99B | USD | Point-in-time |
| Allowance for Accounts receivable |
AllowanceForDoubtfulAccountsReceivable
|
$5.33B | USD | Point-in-time |
| Allowance for Accounts receivable |
AllowanceForDoubtfulAccountsReceivable
|
$5.01B | USD | Point-in-time |
| Debt issuance cost |
DeferredFinanceCostsNoncurrentNet
|
$164.00M | USD | Point-in-time |
| Debt issuance cost |
DeferredFinanceCostsNoncurrentNet
|
$170.00M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$566.00M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$646.00M | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$741.00M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$732.00M | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.80B | shares | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts of $5,488 and $4,988 |
AccountsReceivableNetCurrent
|
$5.83B | USD | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts of $5,488 and $4,988 |
AccountsReceivableNetCurrent
|
$6.50B | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.80B | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
350.09M | shares | Point-in-time |
| Inventories |
InventoryNet
|
$1.50B | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
370.54M | shares | Point-in-time |
| Inventories |
InventoryNet
|
$1.57B | USD | Point-in-time |
| Other |
OtherAssetsCurrent
|
$1.11B | USD | Point-in-time |
| Other |
OtherAssetsCurrent
|
$1.17B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$9.09B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$9.98B | USD | Point-in-time |
| Land |
Land
|
$1.61B | USD | Point-in-time |
| Land |
Land
|
$1.75B | USD | Point-in-time |
| Buildings |
BuildingsAndImprovementsGross
|
$13.55B | USD | Point-in-time |
| Buildings |
BuildingsAndImprovementsGross
|
$14.25B | USD | Point-in-time |
| Equipment |
MachineryAndEquipmentGross
|
$20.58B | USD | Point-in-time |
| Equipment |
MachineryAndEquipmentGross
|
$22.17B | USD | Point-in-time |
| Construction in progress |
ConstructionInProgressGross
|
$1.92B | USD | Point-in-time |
| Construction in progress |
ConstructionInProgressGross
|
$1.32B | USD | Point-in-time |
| Property and equipment, at cost |
PropertyPlantAndEquipmentGross
|
$37.05B | USD | Point-in-time |
| Property and equipment, at cost |
PropertyPlantAndEquipmentGross
|
$40.08B | USD | Point-in-time |
| Accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$20.70B | USD | Point-in-time |
| Accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$22.19B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$17.89B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$16.35B | USD | Point-in-time |
| Investments of insurance subsidiaries |
AvailableForSaleSecuritiesNoncurrent
|
$336.00M | USD | Point-in-time |
| Investments of insurance subsidiaries |
AvailableForSaleSecuritiesNoncurrent
|
$418.00M | USD | Point-in-time |
| Investments in and advances to affiliates |
EquityMethodInvestments
|
$199.00M | USD | Point-in-time |
| Investments in and advances to affiliates |
EquityMethodInvestments
|
$206.00M | USD | Point-in-time |
| Goodwill and other intangible assets |
IntangibleAssetsNetIncludingGoodwill
|
$6.70B | USD | Point-in-time |
| Goodwill and other intangible assets |
IntangibleAssetsNetIncludingGoodwill
|
$6.42B | USD | Point-in-time |
| Goodwill and other intangible assets |
IntangibleAssetsNetIncludingGoodwill
|
$6.73B | USD | Point-in-time |
| Goodwill and other intangible assets |
IntangibleAssetsNetIncludingGoodwill
|
$7.39B | USD | Point-in-time |
| Other |
OtherAssetsNoncurrent
|
$1.07B | USD | Point-in-time |
| Other |
OtherAssetsNoncurrent
|
$710.00M | USD | Point-in-time |
| Total assets |
Assets
|
$33.76B | USD | Point-in-time |
| Total assets |
Assets
|
$32.74B | USD | Point-in-time |
| Total assets |
Assets
|
$36.59B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$2.32B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$2.61B | USD | Point-in-time |
| Accrued salaries |
AccruedSalariesCurrent
|
$1.37B | USD | Point-in-time |
| Accrued salaries |
AccruedSalariesCurrent
|
$1.26B | USD | Point-in-time |
| Other accrued expenses |
OtherAccruedLiabilitiesCurrent
|
$1.98B | USD | Point-in-time |
| Other accrued expenses |
OtherAccruedLiabilitiesCurrent
|
$2.04B | USD | Point-in-time |
| Long-term debt due within one year |
LongTermDebtCurrent
|
$200.00M | USD | Point-in-time |
| Long-term debt due within one year |
LongTermDebtCurrent
|
$216.00M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$6.16B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$5.83B | USD | Point-in-time |
| Long-term debt, less net debt issuance costs of $164 and $170 |
LongTermDebtNoncurrent
|
$32.86B | USD | Point-in-time |
| Long-term debt, less net debt issuance costs of $164 and $170 |
LongTermDebtNoncurrent
|
$31.16B | USD | Point-in-time |
| Professional liability risks |
ProfessionalLiabilityRisks
|
$1.15B | USD | Point-in-time |
| Professional liability risks |
ProfessionalLiabilityRisks
|
$1.20B | USD | Point-in-time |
| Income taxes and other liabilities |
IncomeTaxesAndOtherLiabilities
|
$1.25B | USD | Point-in-time |
| Income taxes and other liabilities |
IncomeTaxesAndOtherLiabilities
|
$1.37B | USD | Point-in-time |
| Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 350,091,600 shares - 2017 and 370,535,900 shares - 2016 |
CommonStockValueOutstanding
|
$4.00M | USD | Point-in-time |
| Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 350,091,600 shares - 2017 and 370,535,900 shares - 2016 |
CommonStockValueOutstanding
|
$4.00M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-265.00M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-323.00M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-278.00M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-338.00M | USD | Point-in-time |
| Retained deficit |
RetainedEarningsAccumulatedDeficit
|
$-6.97B | USD | Point-in-time |
| Retained deficit |
RetainedEarningsAccumulatedDeficit
|
$-6.53B | USD | Point-in-time |
| Stockholders' deficit attributable to HCA Healthcare, Inc. |
StockholdersEquity
|
$-7.30B | USD | Point-in-time |
| Stockholders' deficit attributable to HCA Healthcare, Inc. |
StockholdersEquity
|
$-6.81B | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$1.67B | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$1.81B | USD | Point-in-time |
| Total stockholders' deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-6.05B | USD | Point-in-time |
| Total stockholders' deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-6.50B | USD | Point-in-time |
| Total stockholders' deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-5.00B | USD | Point-in-time |
| Total stockholders' deficit |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-5.63B | USD | Point-in-time |
| Total liabilities and stockholders' deficit |
LiabilitiesAndStockholdersEquity
|
$33.76B | USD | Point-in-time |
| Total liabilities and stockholders' deficit |
LiabilitiesAndStockholdersEquity
|
$36.59B | USD | Point-in-time |
Income Statement
115 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenues before provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenue
|
$43.59B | USD | Annual |
| Revenues before provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenue
|
$47.65B | USD | Annual |
| Revenues before provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenue
|
$44.75B | USD | Annual |
| Provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$3.26B | USD | Annual |
| Provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$4.04B | USD | Annual |
| Provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$3.91B | USD | Annual |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$10.26B | USD | 1 Quarter |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$10.73B | USD | 1 Quarter |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$10.70B | USD | 1 Quarter |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$10.64B | USD | 1 Quarter |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$10.27B | USD | 1 Quarter |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$10.62B | USD | 1 Quarter |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$41.49B | USD | Annual |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$39.68B | USD | Annual |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$43.61B | USD | Annual |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$11.56B | USD | 1 Quarter |
| Revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$10.32B | USD | 1 Quarter |
| Salaries and benefits |
LaborAndRelatedExpense
|
$20.06B | USD | Annual |
| Salaries and benefits |
LaborAndRelatedExpense
|
$18.11B | USD | Annual |
| Salaries and benefits |
LaborAndRelatedExpense
|
$18.90B | USD | Annual |
| Supplies |
SuppliesExpense
|
$6.64B | USD | Annual |
| Supplies |
SuppliesExpense
|
$7.32B | USD | Annual |
| Supplies |
SuppliesExpense
|
$6.93B | USD | Annual |
| Other operating expenses |
OtherCostAndExpenseOperating
|
$7.50B | USD | Annual |
| Other operating expenses |
OtherCostAndExpenseOperating
|
$7.06B | USD | Annual |
| Other operating expenses |
OtherCostAndExpenseOperating
|
$8.05B | USD | Annual |
| Equity in earnings of affiliates |
IncomeLossFromEquityMethodInvestments
|
$46.00M | USD | Annual |
| Equity in earnings of affiliates |
IncomeLossFromEquityMethodInvestments
|
$54.00M | USD | Annual |
| Equity in earnings of affiliates |
IncomeLossFromEquityMethodInvestments
|
$45.00M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$2.13B | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.97B | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.90B | USD | Annual |
| Interest expense |
InterestExpense
|
$1.67B | USD | Annual |
| Interest expense |
InterestExpense
|
$1.71B | USD | Annual |
| Interest expense |
InterestExpense
|
$1.69B | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-4.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$23.00M | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-1.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-15.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-1.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-2.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-5.00M | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$8.00M | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-1.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-4.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-2.00M | USD | 1 Quarter |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-25.00M | USD | 1 Quarter |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-39.00M | USD | Annual |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-2.00M | USD | 1 Quarter |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-4.00M | USD | Annual |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-135.00M | USD | Annual |
| Legal claim costs (benefits) |
LegalClaimCostsBenefits
|
$249.00M | USD | Annual |
| Legal claim costs (benefits) |
LegalClaimCostsBenefits
|
$-246.00M | USD | Annual |
| Total expenses including equity in earnings of affiliates |
ExpensesIncludingEquityInEarningsOfAffiliates
|
$36.68B | USD | Annual |
| Total expenses including equity in earnings of affiliates |
ExpensesIncludingEquityInEarningsOfAffiliates
|
$39.23B | USD | Annual |
| Total expenses including equity in earnings of affiliates |
ExpensesIncludingEquityInEarningsOfAffiliates
|
$35.72B | USD | Annual |
| Income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$3.96B | USD | Annual |
| Income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$4.38B | USD | Annual |
| Income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$4.81B | USD | Annual |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$1.38B | USD | Annual |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$1.26B | USD | Annual |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$1.64B | USD | Annual |
| Net income |
ProfitLoss
|
$530.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.70B | USD | Annual |
| Net income |
ProfitLoss
|
$3.43B | USD | Annual |
| Net income |
ProfitLoss
|
$795.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$791.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$641.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.08B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.74B | USD | Annual |
| Net income |
ProfitLoss
|
$777.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$745.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$811.00M | USD | 1 Quarter |
| Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$542.00M | USD | Annual |
| Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$527.00M | USD | Annual |
| Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$567.00M | USD | Annual |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$2.22B | USD | Annual |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$2.89B | USD | Annual |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$694.00M | USD | 1 Quarter |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$920.00M | USD | 1 Quarter |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$659.00M | USD | 1 Quarter |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$2.13B | USD | Annual |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$657.00M | USD | 1 Quarter |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$658.00M | USD | 1 Quarter |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$426.00M | USD | 1 Quarter |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$474.00M | USD | 1 Quarter |
| Net income attributable to HCA Healthcare, Inc. |
NetIncomeLoss
|
$618.00M | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$5.14 | USD | Annual |
| Basic earnings per share |
EarningsPerShareBasic
|
$6.12 | USD | Annual |
| Basic earnings per share |
EarningsPerShareBasic
|
$1.78 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$1.75 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$2.46 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$1.18 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$1.70 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$1.79 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$1.34 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$1.63 | USD | 1 Quarter |
| Basic earnings per share |
EarningsPerShareBasic
|
$7.53 | USD | Annual |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$7.30 | USD | Annual |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$1.15 | USD | 1 Quarter |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$1.65 | USD | 1 Quarter |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$5.95 | USD | Annual |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$4.99 | USD | Annual |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$1.74 | USD | 1 Quarter |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$1.59 | USD | 1 Quarter |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$1.69 | USD | 1 Quarter |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$1.75 | USD | 1 Quarter |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$1.30 | USD | 1 Quarter |
| Diluted earnings per share |
EarningsPerShareDiluted
|
$2.39 | USD | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
383.59M | shares | Annual |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
362.31M | shares | Annual |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
414.19M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
395.85M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
372.22M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
426.72M | shares | Annual |
Cash Flow Statement
121 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$530.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.70B | USD | Annual |
| Net income |
ProfitLoss
|
$3.43B | USD | Annual |
| Net income |
ProfitLoss
|
$795.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$791.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$641.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.08B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.74B | USD | Annual |
| Net income |
ProfitLoss
|
$777.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$745.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$811.00M | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$4.64B | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$4.11B | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$3.25B | USD | Annual |
| Provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$3.26B | USD | Annual |
| Provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$4.04B | USD | Annual |
| Provision for doubtful accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$3.91B | USD | Annual |
| Accounts receivable, net |
IncreaseDecreaseInReceivables
|
$201.00M | USD | Annual |
| Accounts receivable, net |
IncreaseDecreaseInReceivables
|
$-10.00M | USD | Annual |
| Accounts receivable, net |
IncreaseDecreaseInReceivables
|
$601.00M | USD | Annual |
| Inventories and other assets |
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
|
$314.00M | USD | Annual |
| Inventories and other assets |
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
|
$112.00M | USD | Annual |
| Inventories and other assets |
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
|
$69.00M | USD | Annual |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$144.00M | USD | Annual |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$192.00M | USD | Annual |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$374.00M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$2.13B | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.97B | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.90B | USD | Annual |
| Income taxes |
DeferredIncomeTaxesAndTaxCredits
|
$-160.00M | USD | Annual |
| Income taxes |
DeferredIncomeTaxesAndTaxCredits
|
$433.00M | USD | Annual |
| Income taxes |
DeferredIncomeTaxesAndTaxCredits
|
$123.00M | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-4.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$23.00M | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-1.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-15.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-1.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-2.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-5.00M | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$8.00M | USD | Annual |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-1.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-4.00M | USD | 1 Quarter |
| Losses (gains) on sales of facilities |
GainLossOnDispositionOfAssets
|
$-2.00M | USD | 1 Quarter |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-25.00M | USD | 1 Quarter |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-39.00M | USD | Annual |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-2.00M | USD | 1 Quarter |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-4.00M | USD | Annual |
| Losses on retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-135.00M | USD | Annual |
| Legal claim costs (benefits) |
LegalClaimCostsBenefits
|
$249.00M | USD | Annual |
| Legal claim costs (benefits) |
LegalClaimCostsBenefits
|
$-246.00M | USD | Annual |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$31.00M | USD | Annual |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$34.00M | USD | Annual |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$35.00M | USD | Annual |
| Share-based compensation |
ShareBasedCompensation
|
$251.00M | USD | Annual |
| Share-based compensation |
ShareBasedCompensation
|
$239.00M | USD | Annual |
| Share-based compensation |
ShareBasedCompensation
|
$270.00M | USD | Annual |
| Other |
OtherNoncashIncomeExpense
|
$-70.00M | USD | Annual |
| Other |
OtherNoncashIncomeExpense
|
$-83.00M | USD | Annual |
| Other |
OtherNoncashIncomeExpense
|
$-54.00M | USD | Annual |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$4.73B | USD | Annual |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$5.43B | USD | Annual |
| Net cash provided by (used in) operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$5.65B | USD | Annual |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$2.76B | USD | Annual |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$2.38B | USD | Annual |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$3.02B | USD | Annual |
| Acquisition of hospitals and health care entities |
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
$576.00M | USD | Annual |
| Acquisition of hospitals and health care entities |
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
$351.00M | USD | Annual |
| Acquisition of hospitals and health care entities |
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
$1.21B | USD | Annual |
| Disposal of hospitals and health care entities |
ProceedsFromDivestitureOfBusinesses
|
$25.00M | USD | Annual |
| Disposal of hospitals and health care entities |
ProceedsFromDivestitureOfBusinesses
|
$73.00M | USD | Annual |
| Disposal of hospitals and health care entities |
ProceedsFromDivestitureOfBusinesses
|
$26.00M | USD | Annual |
| Change in investments |
PaymentsForProceedsFromInvestments
|
$73.00M | USD | Annual |
| Change in investments |
PaymentsForProceedsFromInvestments
|
$-64.00M | USD | Annual |
| Change in investments |
PaymentsForProceedsFromInvestments
|
$-63.00M | USD | Annual |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$4.00M | USD | Annual |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$-6.00M | USD | Annual |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$-7.00M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-2.58B | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-3.24B | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-4.28B | USD | Annual |
| Issuances of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
$1.50B | USD | Annual |
| Issuances of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
$5.55B | USD | Annual |
| Issuances of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
$5.40B | USD | Annual |
| Net change in revolving bank credit facilities |
ProceedsFromRepaymentsOfLinesOfCredit
|
$760.00M | USD | Annual |
| Net change in revolving bank credit facilities |
ProceedsFromRepaymentsOfLinesOfCredit
|
$150.00M | USD | Annual |
| Net change in revolving bank credit facilities |
ProceedsFromRepaymentsOfLinesOfCredit
|
$-110.00M | USD | Annual |
| Repayment of long-term debt |
RepaymentsOfLongTermDebt
|
$753.00M | USD | Annual |
| Repayment of long-term debt |
RepaymentsOfLongTermDebt
|
$4.47B | USD | Annual |
| Repayment of long-term debt |
RepaymentsOfLongTermDebt
|
$4.92B | USD | Annual |
| Distributions to noncontrolling interests |
PaymentsOfDividendsMinorityInterest
|
$448.00M | USD | Annual |
| Distributions to noncontrolling interests |
PaymentsOfDividendsMinorityInterest
|
$495.00M | USD | Annual |
| Distributions to noncontrolling interests |
PaymentsOfDividendsMinorityInterest
|
$434.00M | USD | Annual |
| Payment of debt issuance costs |
PaymentsOfDebtIssuanceCosts
|
$40.00M | USD | Annual |
| Payment of debt issuance costs |
PaymentsOfDebtIssuanceCosts
|
$26.00M | USD | Annual |
| Payment of debt issuance costs |
PaymentsOfDebtIssuanceCosts
|
$50.00M | USD | Annual |
| Repurchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$2.05B | USD | Annual |
| Repurchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$2.75B | USD | Annual |
| Repurchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$2.40B | USD | Annual |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$188.00M | USD | Annual |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-98.00M | USD | Annual |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-45.00M | USD | Annual |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-2.51B | USD | Annual |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-1.06B | USD | Annual |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-1.98B | USD | Annual |
| Change in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-95.00M | USD | Annual |
| Change in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$175.00M | USD | Annual |
| Change in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$86.00M | USD | Annual |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$566.00M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$646.00M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$741.00M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$732.00M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$566.00M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$646.00M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$741.00M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$732.00M | USD | Point-in-time |
| Interest payments |
InterestPaidNet
|
$1.65B | USD | Annual |
| Interest payments |
InterestPaidNet
|
$1.70B | USD | Annual |
| Interest payments |
InterestPaidNet
|
$1.67B | USD | Annual |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$1.19B | USD | Annual |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$1.21B | USD | Annual |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$1.25B | USD | Annual |
Stockholders Equity
29 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-6.05B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-6.50B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-5.00B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-5.63B | USD | Point-in-time |
| Comprehensive income (loss) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$3.36B | USD | Annual |
| Comprehensive income (loss) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$2.75B | USD | Annual |
| Comprehensive income (loss) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$2.80B | USD | Annual |
| Repurchase of common stock |
StockRepurchasedDuringPeriodValue
|
$2.40B | USD | Annual |
| Repurchase of common stock |
StockRepurchasedDuringPeriodValue
|
$2.75B | USD | Annual |
| Repurchase of common stock |
StockRepurchasedDuringPeriodValue
|
$2.05B | USD | Annual |
| Repurchase of common stock, shares |
StockRepurchasedDuringPeriodShares
|
31.99M | shares | Annual |
| Repurchase of common stock, shares |
StockRepurchasedDuringPeriodShares
|
25.09M | shares | Annual |
| Repurchase of common stock, shares |
StockRepurchasedDuringPeriodShares
|
36.33M | shares | Annual |
| Repurchase of common stock, shares |
StockRepurchasedDuringPeriodShares
|
25.09M | shares | Point-in-time |
| Share-based benefit plans |
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
$281.00M | USD | Annual |
| Share-based benefit plans |
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
$233.00M | USD | Annual |
| Share-based benefit plans |
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
$523.00M | USD | Annual |
| Distributions |
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
$495.00M | USD | Annual |
| Distributions |
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
$448.00M | USD | Annual |
| Distributions |
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
$434.00M | USD | Annual |
| Acquisition of entities with noncontrolling interests |
NoncontrollingInterestIncreaseFromBusinessCombination
|
$63.00M | USD | Annual |
| Acquisition of entities with noncontrolling interests |
NoncontrollingInterestIncreaseFromBusinessCombination
|
$85.00M | USD | Annual |
| Other |
StockholdersEquityOther
|
$18.00M | USD | Annual |
| Other |
StockholdersEquityOther
|
$-6.00M | USD | Annual |
| Other |
StockholdersEquityOther
|
$10.00M | USD | Annual |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-6.05B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-6.50B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-5.00B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-5.63B | USD | Point-in-time |
Comprehensive Income
57 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$530.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.70B | USD | Annual |
| Net income |
ProfitLoss
|
$3.43B | USD | Annual |
| Net income |
ProfitLoss
|
$795.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$791.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$641.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.08B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.74B | USD | Annual |
| Net income |
ProfitLoss
|
$777.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$745.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$811.00M | USD | 1 Quarter |
| Foreign currency translation |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
$-63.00M | USD | Annual |
| Foreign currency translation |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
$97.00M | USD | Annual |
| Foreign currency translation |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
$-224.00M | USD | Annual |
| Unrealized gains (losses) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$1.00M | USD | Annual |
| Unrealized gains (losses) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-9.00M | USD | Annual |
| Unrealized gains (losses) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$1.00M | USD | Annual |
| Realized gains included in other operating expenses |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$2.00M | USD | Annual |
| Total unrealized gains (losses) on available-for-sale securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
$-1.00M | USD | Annual |
| Total unrealized gains (losses) on available-for-sale securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
$-9.00M | USD | Annual |
| Total unrealized gains (losses) on available-for-sale securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
$1.00M | USD | Annual |
| Defined benefit plans |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
|
$30.00M | USD | Annual |
| Defined benefit plans |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
|
$-35.00M | USD | Annual |
| Defined benefit plans |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
|
$-43.00M | USD | Annual |
| Pension costs included in salaries and benefits |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
$-18.00M | USD | Annual |
| Pension costs included in salaries and benefits |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
$-32.00M | USD | Annual |
| Pension costs included in salaries and benefits |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
$-18.00M | USD | Annual |
| Total defined benefit plans |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
|
$17.00M | USD | Annual |
| Total defined benefit plans |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
|
$25.00M | USD | Annual |
| Total defined benefit plans |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
|
$-62.00M | USD | Annual |
| Change in fair value of derivative financial instruments |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
|
$11.00M | USD | Annual |
| Change in fair value of derivative financial instruments |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
|
$-36.00M | USD | Annual |
| Change in fair value of derivative financial instruments |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
|
$20.00M | USD | Annual |
| Interest costs included in interest expense |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
|
$-109.00M | USD | Annual |
| Interest costs included in interest expense |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
|
$-125.00M | USD | Annual |
| Interest costs included in interest expense |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
|
$-20.00M | USD | Annual |
| Total change in fair value of derivative financial instruments |
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
|
$89.00M | USD | Annual |
| Total change in fair value of derivative financial instruments |
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
|
$31.00M | USD | Annual |
| Total change in fair value of derivative financial instruments |
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
|
$129.00M | USD | Annual |
| Other comprehensive income (loss) before taxes |
OtherComprehensiveIncomeLossBeforeTax
|
$89.00M | USD | Annual |
| Other comprehensive income (loss) before taxes |
OtherComprehensiveIncomeLossBeforeTax
|
$102.00M | USD | Annual |
| Other comprehensive income (loss) before taxes |
OtherComprehensiveIncomeLossBeforeTax
|
$-121.00M | USD | Annual |
| Income taxes (benefits) related to other comprehensive income items |
OtherComprehensiveIncomeLossTax
|
$42.00M | USD | Annual |
| Income taxes (benefits) related to other comprehensive income items |
OtherComprehensiveIncomeLossTax
|
$31.00M | USD | Annual |
| Income taxes (benefits) related to other comprehensive income items |
OtherComprehensiveIncomeLossTax
|
$-48.00M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$60.00M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$58.00M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-73.00M | USD | Annual |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$3.36B | USD | Annual |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$2.75B | USD | Annual |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$2.80B | USD | Annual |
| Comprehensive income attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$567.00M | USD | Annual |
| Comprehensive income attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$542.00M | USD | Annual |
| Comprehensive income attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$527.00M | USD | Annual |
| Comprehensive income attributable to HCA Healthcare, Inc. |
ComprehensiveIncomeNetOfTax
|
$2.19B | USD | Annual |
| Comprehensive income attributable to HCA Healthcare, Inc. |
ComprehensiveIncomeNetOfTax
|
$2.82B | USD | Annual |
| Comprehensive income attributable to HCA Healthcare, Inc. |
ComprehensiveIncomeNetOfTax
|
$2.28B | USD | Annual |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.